secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2021-09-29T23:59:59+00:00
Accession:  0001193125-21-286870
Event type: leadership
Sentiment:  negative
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coherus BioSciences announces passing of board member Dr. Samuel Nussbaum
-------------------------------------------------------------------------

- Dr. Samuel Nussbaum passed away on September 23, 2021.
- He had served as a director of Coherus since May 2018.
- CEO Denny Lanfear expressed gratitude for Dr. Nussbaum's guidance and support.
- Dr. Nussbaum was former EVP, Chief Medical Officer at Anthem from 2000 to 2016.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000119312521286870/0001193125-21-286870-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000119312521286870/d119636d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-286870

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer